Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Metagenomi (MGX) Income from Continuing Operations (2023 - 2025)

Metagenomi (MGX) has disclosed Income from Continuing Operations for 3 consecutive years, with 22528000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations rose 3.72% to 22528000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 87868000.0, a 12.57% decrease, with the full-year FY2025 number at 87868000.0, down 12.57% from a year prior.
  • Income from Continuing Operations was 22528000.0 for Q4 2025 at Metagenomi, down from 20393000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 10739000.0 in Q2 2024 to a low of 25148000.0 in Q1 2024.
  • A 3-year average of 19515083.33 and a median of 19864000.0 in 2023 define the central range for Income from Continuing Operations.
  • Biggest YoY gain for Income from Continuing Operations was 38.29% in 2024; the steepest drop was 114.23% in 2024.
  • Metagenomi's Income from Continuing Operations stood at 19294000.0 in 2023, then fell by 21.27% to 23398000.0 in 2024, then increased by 3.72% to 22528000.0 in 2025.
  • Per Business Quant, the three most recent readings for MGX's Income from Continuing Operations are 22528000.0 (Q4 2025), 20393000.0 (Q3 2025), and 19908000.0 (Q2 2025).